Carol Werther

Analyst Carol Werther, carries an average stock price target met ratio of 75% that have a potential upside of 35.64% achieved within 544 days. Previously, Carol Werther worked at DAWSON JAMES, SUMMER STREET.

Carol Werther’s has documented 23 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on RARE, Ultragenyx at 19-Apr-2017.

Wall Street Analyst Carol Werther

Analyst best performing recommendations are on LGND (LIGAND PHARMACEUTICALS).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/12/2014. The price target of $49.38 was fulfilled within 1 day with a profit of $2.95 (6.35%) receiving and performance score of 63.54.

Average potential price target upside

• of $44.38 (75.77%) on RARE (ULTRAGENYX).
• of $24.18 (32.75%) on CELG (CELGENE).
• of $20.03 (34.05%) on LGND (LIGAND PHARMACEUTICALS).